A citation-based method for searching scientific literature

Natasha S R Bidesi, Ida Vang Andersen, Albert D Windhorst, Vladimir Shalgunov, Matthias M Herth. J Neurochem 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.
Thomas G Beach, Charles H Adler, LihFen Lue, Lucia I Sue, Jyothi Bachalakuri, Jonette Henry-Watson, Jeanne Sasse, Sarah Boyer, Scophil Shirohi, Reed Brooks,[...]. Acta Neuropathol 2009
396
50

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
Nora D Volkow, Joanna S Fowler, Jean Logan, David Alexoff, Wei Zhu, Frank Telang, Gene-Jack Wang, Millard Jayne, Jacob M Hooker, Christopher Wong,[...]. JAMA 2009
348
50

Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases.
Merijn Joling, Chris Vriend, Odile A van den Heuvel, Pieter G H M Raijmakers, Paul A Jones, Henk W Berendse, Jan Booij. J Nucl Med 2017
20
50

Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.
David Matuskey, Sule Tinaz, Kyle C Wilcox, Mika Naganawa, Takuya Toyonaga, Mark Dias, Shannan Henry, Brian Pittman, Jim Ropchan, Nabeel Nabulsi,[...]. Ann Neurol 2020
54
50

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.
Maria C Rodriguez-Oroz, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl Macias, Erwan Bezard, José A Obeso. Lancet Neurol 2009
454
50

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
M Plotkin, H Amthauer, S Klaffke, A Kühn, L Lüdemann, G Arnold, K-D Wernecke, A Kupsch, R Felix, S Venz. J Neural Transm (Vienna) 2005
147
50

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.
John T O'Brien, Ian G McKeith, Zuzana Walker, Klaus Tatsch, Jan Booij, Jacques Darcourt, Moritz Marquardt, Cornelia Reininger. Br J Psychiatry 2009
87
50

The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease.
Orazio Schillaci, Mariangela Pierantozzi, Luca Filippi, Carlo Manni, Livia Brusa, Roberta Danieli, Giorgio Bernardi, Giovanni Simonetti, Paolo Stanzione. Eur J Nucl Med Mol Imaging 2005
46
50

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
D J Brooks, V Ibanez, G V Sawle, E D Playford, N Quinn, C J Mathias, A J Lees, C D Marsden, R Bannister, R S Frackowiak. Ann Neurol 1992
347
50

Scan without evidence of dopaminergic deficit: A 10-year retrospective study.
Nicolas Nicastro, Valentina Garibotto, Simon Badoud, Pierre R Burkhard. Parkinsonism Relat Disord 2016
25
50

L-Dopa for Parkinsonism.
G C Cotzias. N Engl J Med 1968
64
50

Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Helen Ling, Sean S O'Sullivan, Janice L Holton, Tamas Revesz, Luke A Massey, David R Williams, Dominic C Paviour, Andrew J Lees. Brain 2010
256
50


Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Nicolaas I Bohnen, Roger L Albin, Robert A Koeppe, Kristine A Wernette, Michael R Kilbourn, Satoshi Minoshima, Kirk A Frey. J Cereb Blood Flow Metab 2006
177
50

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.
Manuel Menéndez-González, Francisco Tavares, Nahla Zeidan, José M Salas-Pacheco, Oscar Arias-Carrión. Front Aging Neurosci 2014
31
50

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
50

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Luca Passamonti, Patricia Vázquez Rodríguez, Young T Hong, Kieren S J Allinson, David Williamson, Robin J Borchert, Saber Sami, Thomas E Cope, W Richard Bevan-Jones, P Simon Jones,[...]. Brain 2017
144
50


Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
Dennis W Dickson, Heiko Braak, John E Duda, Charles Duyckaerts, Thomas Gasser, Glenda M Halliday, John Hardy, James B Leverenz, Kelly Del Tredici, Zbigniew K Wszolek,[...]. Lancet Neurol 2009
510
50

11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies.
Nicolas Nicastro, Negin Holland, George Savulich, Stephen F Carter, Elijah Mak, Young T Hong, Selena Milicevic Sephton, Tim D Fryer, Franklin I Aigbirhio, James B Rowe,[...]. Eur J Hybrid Imaging 2020
6
50

123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Luca Filippi, Carlo Manni, Mariangela Pierantozzi, Livia Brusa, Roberta Danieli, Paolo Stanzione, Orazio Schillaci. Nucl Med Commun 2006
28
50

The natural history of multiple system atrophy: a prospective European cohort study.
Gregor K Wenning, Felix Geser, Florian Krismer, Klaus Seppi, Susanne Duerr, Sylvia Boesch, Martin Köllensperger, Georg Goebel, Karl P Pfeiffer, Paolo Barone,[...]. Lancet Neurol 2013
278
50

Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Julia Kraemmer, Gabor G Kovacs, Laura Perju-Dumbrava, Susanne Pirker, Tatiana Traub-Weidinger, Walter Pirker. Mov Disord 2014
81
50

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
E Nurmi, H M Ruottinen, J Bergman, M Haaparanta, O Solin, P Sonninen, J O Rinne. Mov Disord 2001
154
50

Clinical and [18F] dopa PET findings in early Parkinson's disease.
P K Morrish, G V Sawle, D J Brooks. J Neurol Neurosurg Psychiatry 1995
187
50

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
598
50

EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
Koen Van Laere, Andrea Varrone, Jan Booij, Thierry Vander Borght, Flavio Nobili, Ozlem L Kapucu, Zuzana Walker, Kjell Någren, Klaus Tatsch, Jacques Darcourt. Eur J Nucl Med Mol Imaging 2010
36
50


Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Günter U Höglinger, Gesine Respondek, Maria Stamelou, Carolin Kurz, Keith A Josephs, Anthony E Lang, Brit Mollenhauer, Ulrich Müller, Christer Nilsson, Jennifer L Whitwell,[...]. Mov Disord 2017
753
50

Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of Parkinsonism.
Fermín Segovia, Juan M Górriz, Javier Ramírez, Francisco J Martínez-Murcia, Johannes Levin, Madeleine Schuberth, Matthias Brendel, Axel Rominger, Kai Bötzel, Gaëtan Garraux,[...]. Front Neuroinform 2017
13
50

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Lauren Hirsch, Nathalie Jette, Alexandra Frolkis, Thomas Steeves, Tamara Pringsheim. Neuroepidemiology 2016
239
50

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.
Roberto Cilia, Carlo Rossi, Daniela Frosini, Duccio Volterrani, Chiara Siri, Cristina Pagni, Riccardo Benti, Gianni Pezzoli, Ubaldo Bonuccelli, Angelo Antonini,[...]. PLoS One 2011
59
50


The development and validation of tau PET tracers: current status and future directions.
Nobuyuki Okamura, Ryuichi Harada, Aiko Ishiki, Akio Kikuchi, Tadaho Nakamura, Yukitsuka Kudo. Clin Transl Imaging 2018
81
50

Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Alex Iranzo, Joan Santamaría, Francesc Valldeoriola, Monica Serradell, Manel Salamero, Carles Gaig, Aida Niñerola-Baizán, Raquel Sánchez-Valle, Albert Lladó, Roberto De Marzi,[...]. Ann Neurol 2017
99
50

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
Friederike Sixel-Döring, Knut Liepe, Brit Mollenhauer, Ellen Trautmann, Claudia Trenkwalder. J Neurol 2011
39
50

Epidemiologic aspects.
D M Togasaki, C M Tanner. Adv Neurol 2000
33
50

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.
Roberto Erro, Susanne A Schneider, Maria Stamelou, Niall P Quinn, Kailash P Bhatia. J Neurol Neurosurg Psychiatry 2016
78
50

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
Ian McKeith, John O'Brien, Zuzana Walker, Klaus Tatsch, Jan Booij, Jacques Darcourt, Alessandro Padovani, Raffaele Giubbini, Ubaldo Bonuccelli, Duccio Volterrani,[...]. Lancet Neurol 2007
361
50

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
J Booij, G Tissingh, G J Boer, J D Speelman, J C Stoof, A G Janssen, E C Wolters, E A van Royen. J Neurol Neurosurg Psychiatry 1997
241
50

How valid is the clinical diagnosis of Parkinson's disease in the community?
A Schrag, Y Ben-Shlomo, N Quinn. J Neurol Neurosurg Psychiatry 2002
164
50


Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
Vicky L Marshall, Cornelia B Reininger, Moritz Marquardt, Jim Patterson, Donald M Hadley, Wolfgang H Oertel, Hani T S Benamer, Paul Kemp, David Burn, Eduardo Tolosa,[...]. Mov Disord 2009
132
50

Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: a voxel-based analysis of [123I]β-CIT SPECT.
Michael Nocker, Klaus Seppi, Eveline Donnemiller, Irene Virgolini, Gregor K Wenning, Werner Poewe, Christoph Scherfler. Eur J Nucl Med Mol Imaging 2012
31
50

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
M G Spillantini, R A Crowther, R Jakes, N J Cairns, P L Lantos, M Goedert. Neurosci Lett 1998
710
50


Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
N Vanacore, V Bonifati, G Fabbrini, C Colosimo, G De Michele, R Marconi, D Nicholl, N Locuratolo, G Talarico, S Romano,[...]. Neurol Sci 2001
38
50

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.
I Litvan, J J Hauw, J J Bartko, P L Lantos, S E Daniel, D S Horoupian, A McKee, D Dickson, C Bancher, M Tabaton,[...]. J Neuropathol Exp Neurol 1996
374
50

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.
Silvia Morbelli, Giuseppe Esposito, Javier Arbizu, Henryk Barthel, Ronald Boellaard, Nico I Bohnen, David J Brooks, Jacques Darcourt, John C Dickson, David Douglas,[...]. Eur J Nucl Med Mol Imaging 2020
33
50

Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
Dario Arnaldi, Andrea Chincarini, Michele T Hu, Karel Sonka, Bradley Boeve, Tomoyuki Miyamoto, Monica Puligheddu, Valérie Cochen De Cock, Michele Terzaghi, Giuseppe Plazzi,[...]. Brain 2021
17
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.